Stock Analiz

Arcturus Therapeutics Holdings Inc. (ARCT) stock forecast and price target

Price $8.36 · data as of November 13, 2026

12-month price target

Average target$23.80
Upside / downside+184.7%
Analysts10
ConsensusStrong buy
Low $9.00Average $23.80High $41.00

Gold marker: average target · white marker: today’s price ($8.36)

Analyst ratings

Strong buy 1Buy 10Hold 2Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.90−20.7%$28M
Next fiscal year
ends December 31, 2027
$-3.33−15.0%$32M
Next quarter
ends December 31, 2026
$-0.83+19.0%$4M
Quarter after
ends March 31, 2027
$-0.88+7.6%$2M

Consensus of the analysts covering Arcturus Therapeutics, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Frequently asked questions

What is the Arcturus Therapeutics stock price target?

The average 12-month target from 10 analysts is $23.80, 184.7% above the current price of $8.36 Targets range from $9.00 to $41.00.

Is Arcturus Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 10 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Arcturus Therapeutics expected to earn?

Analysts expect EPS of $-2.90 for the fiscal year ending December 31, 2026 and $-3.33 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.